Literature DB >> 3774018

Opiates induce long-term increases in prodynorphin-derived peptide levels in the guinea-pig myenteric plexus.

R Schulz, K Metzner, T Dandekar, C Gramsch.   

Abstract

The subcutaneous administration of a single dose of an opiate agonist (levorphanol) or antagonist (naloxone) to guinea pigs results in an at least 3-fold elevation of dynorphin and alpha-neoendorphin-immunoreactivity in the longitudinal muscle myenteric plexus preparation. The effects are time- and dose-dependent, significant elevations first being observed 6 h after treatment and lasting for up to 24 h. Pretreatment levels of opioid peptides were observed after 8 days. Combined injection of the narcotic agonist and antagonist, at sufficiently high doses, resulted in an additive effect of the individual drugs. The respective stereoisomers dextrorphan and (+)-naloxone did not affect prodynorphin-derived peptide concentrations. An increase of endogenous opioids was also observed after administration of the nonopiate clonidine, a compound which, like opiates, alters the activity of the myenteric plexus. It is suggested that feedback mechanisms in the myenteric plexus are responsible for the elevation of endogenous opioid peptides following exposure to exogenous opiates. Using a monoclonal antibody (3-E7), which recognizes virtually all endogenous opioid peptides, it was found that levels of higher molecular material were also increased upon opiate challenge. This suggests that a single dose of an exogenous opiate results in an increase in peptide synthesis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3774018     DOI: 10.1007/bf00500013

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  26 in total

1.  Long-term morphine treatment decreases endorphin levels in rat brain and pituitary.

Authors:  R Przewłocki; V Höllt; T Duka; G Kleber; C Gramsch; I Haarmann; A Herz
Journal:  Brain Res       Date:  1979-10-05       Impact factor: 3.252

2.  Dynorphin-(1-13), an extraordinarily potent opioid peptide.

Authors:  A Goldstein; S Tachibana; L I Lowney; M Hunkapiller; L Hood
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

Review 3.  Physiology of nerve growth factor.

Authors:  H Thoenen; Y A Barde
Journal:  Physiol Rev       Date:  1980-10       Impact factor: 37.312

4.  Isolation and structure of dynorphin, an opioid peptide, from porcine duodenum.

Authors:  S Tachibana; K Araki; S Ohya; S Yoshida
Journal:  Nature       Date:  1982-01-28       Impact factor: 49.962

5.  Release of immunoreactive-dynorphin from the isolated guinea-pig small intestine is reduced during peristaltic activity.

Authors:  W Kromer; V Höllt; H Schmidt; A Herz
Journal:  Neurosci Lett       Date:  1981-08-07       Impact factor: 3.046

6.  Functional opiate receptors in the guinea-pig ileum: their differentiation by means of selective tolerance development.

Authors:  R Schulz; M Wüster; P Rubini; A Herz
Journal:  J Pharmacol Exp Ther       Date:  1981-11       Impact factor: 4.030

7.  beta-Endorphin-like immunoreactivity in plasma, pituitaries and hypothalamus of rats following treatment with opiates.

Authors:  V Höllt; R Przewłocki; A Herz
Journal:  Life Sci       Date:  1978-09-11       Impact factor: 5.037

8.  Opioid binding properties of brain and peripheral tissues: evidence for heterogeneity in opioid ligand binding sites.

Authors:  F M Leslie; C Chavkin; B M Cox
Journal:  J Pharmacol Exp Ther       Date:  1980-08       Impact factor: 4.030

9.  Peristalsis abolishes the release of methionine-enkephalin from guinea-pig ileum in vitro.

Authors:  S J Clark; T W Smith
Journal:  Eur J Pharmacol       Date:  1981-03-26       Impact factor: 4.432

10.  Enkephalin: radioimmunoassay and radioreceptor assay in morphine dependent rats.

Authors:  S R Childers; R Simantov; S H Snyder
Journal:  Eur J Pharmacol       Date:  1977-12-01       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.